Skip to content

ADHOC Mindfulness-Based Research

ADHOC Mindfulness-Based Research - An Intervention to Address Loneliness Among Older People Living With HIV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04580082
Acronym
AMBR
Enrollment
202
Registered
2020-10-08
Start date
2020-05-21
Completion date
2020-09-28
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Hiv, Loneliness

Brief summary

The AMBR Study (ADHOC Mindfulness-Based Research Study) is a randomized controlled trial that examines the effectiveness of teaching mindfulness-based techniques through online lessons to combat loneliness, anxiety, and depression among people living with HIV over the age of 50. It is a substudy of the ADHOC study (ClinicalTrials.gov identifier NCT04311554).

Detailed description

The AMBR Study is a randomized controlled trial that examines the effectiveness of teaching mindfulness-based techniques through online lessons to combat loneliness, anxiety, and depression among people living with HIV who are over the age of 50 and enrolled in ADHOC (ClinicalTrials.gov identifier NCT04311554). The intervention consists of 14 mindfulness audio lessons, each approximately 20-minutes long. The mindfulness lessons are designed to develop three core skills: concentration (the ability to maintain focus on present-moment experiences), clarity (the ability to pinpoint exactly what you are experiencing in each moment), and equanimity (openness to experience).

Interventions

BEHAVIORALMindfulness lessons

14 lessons on mindfulness, each lasting approximately 20 minutes.

Sponsors

Mazonson & Santas Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ADHOC participant with a score of 4 or higher on the 3-item Loneliness Questionnaire from their ADHOC profile * Clinical diagnosis of HIV * Able to read and write in English * Able and willing to provide online informed consent and complete study activities online * Access to a smartphone or computer

Exclusion criteria

\- Acute medical problem(s) requiring immediate inpatient treatment

Design outcomes

Primary

MeasureTime frameDescription
LonelinessBaseline and follow-up, 25 daysChange in loneliness using the 3-Item Loneliness Questionnaire (3IL). 3IL scores range from 3-9, with higher scores indicating greater loneliness.

Secondary

MeasureTime frameDescription
AnxietyBaseline and follow-up, 25 daysChange in anxiety using the 7-item Generalized Anxiety scale (GAD-7). GAD-7 scores range from 0-21, with higher scores indicating more anxiety.
DepressionBaseline and follow-up, 25 daysChange in depression using the 10-item Center for Epidemiologic Studies Depression scale (CES-D-10). CES-D-10 scores range from 0-30, with higher scores indicating more depression.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026